Metrics as of 10/14/2026, 08:12 PM (Berlin time), refresh in progress.
Allergy Therapeutics Stock
Allergy Therapeutics plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United Kingdom
- CEO
- Manuel Llobet
- Employees
- 584
- Market cap
- £285 M
- IPO
- 11/10/2004
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related…
Allergy Therapeutics stock: price history
1D
-5.3%
1W
-5.3%
1M
-13.5%
6M
-57.1%
YTD
-59.1%
1Y
-45.8%
2Y
-10.0%
5Y
-73.2%
10Y
-63.3%
Next earnings date
Next earnings date
04/03/2027 (in 138 days)
Volatility around earnings
~446% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Allergy Therapeutics
Allergy Therapeutics stock metrics
P/E
-4.54
P/B
55.33
EV/EBITDA
-9.7
RETURN ON EQUITY
-468.8%
NET MARGIN
-54.9%
DEBT/EQUITY
6.3
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
Free float & liquidity
FREE FLOAT
11.8%
FLOAT SHARES
744,768,853
AVG. DAILY VOLUME (30D)
133,575
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Allergy Therapeutics stock
What does Allergy Therapeutics do?
Allergy Therapeutics plc is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United Kingdom.
The CEO is Manuel Llobet, the company employs around 584 people.
The IPO was on 11/10/2004; the stock trades on LSE under the ticker AGY.L.
When does Allergy Therapeutics report next?
The next earnings date is 04/03/2027.
Around past earnings, price swings were roughly 446% stronger than usual.
Does Allergy Therapeutics pay a dividend?
No, Allergy Therapeutics currently does not pay a dividend.
Which stocks are comparable to Allergy Therapeutics?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Allergy Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Allergy Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.